RxDoctor Payments Data

Brian Duff, MD

Family Medicine · Nixa, MONPI 1447411145

Payments from drug & device makers

$870in general payments, 2019–2025

Across 51 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$244
  • Novo Nordisk$164
  • AstraZeneca$126
  • AbbVie$87
  • Exact Sciences$83
  • Abbott$62
  • plus $103 from 5 others

What the payments were for

  • Food & beverage$870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$870 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$69,663
Medicare patients
291
Services billed
1,304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide203$205,554
EliquisApixaban228$200,088
Inderal LaPropranolol Hcl13$47,275
Trelegy ElliptaFluticasone/Umeclidin/Vilanter62$46,602
ShingrixVaricella-Zoster Ge/As01b/Pf208$45,490
MounjaroTirzepatide33$38,552
JardianceEmpagliflozin23$36,884
XareltoRivaroxaban20$27,301
SymbicortBudesonide/Formoterol Fumarate63$23,418
Spiriva HandihalerTiotropium Bromide14$18,202
LinzessLinaclotide18$13,862
AltoprevLovastatin12$13,513
Breo ElliptaFluticasone/Vilanterol29$12,697
MyrbetriqMirabegron15$11,895
Combivent RespimatIpratropium/Albuterol Sulfate25$11,844

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$164$205,554203 claims
PfizerEliquis, Abrysvo$244$203,924241 claims
AstraZenecaSymbicort$126$23,41863 claims
AbbVieLinzess$87$13,86218 claims
Astellas Pharma US IncMyrbetriq$23$11,89515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Nixa

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →